Telix Pharmaceuticals TLX
NASDAQ TLX
$10.72 -0.25 (-2.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Telix Pharmaceuticals (TLX) Non-Current Deferred Tax Liability (2024 - 2026)

Updated

Telix Pharmaceuticals' Non-Current Deferred Tax Liability came in at $43.3 million for the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Non-Current Deferred Tax Liability (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Telix Pharmaceuticals' Non-Current Deferred Tax Liability was $44.71 million, up 671.3% from the prior year.

  • Going back by year, Non-Current Deferred Tax Liability was $5.8 million in the year ended Dec 31, 2024.
  • The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Non-Current Deferred Tax Liability since the quarter ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Telix Pharmaceuticals 3.72 Bn 2.66 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.30 Mn
Dec 31, 2025 44.71 Mn
Dec 31, 2024 6.13 Mn
API Access

Telix Pharmaceuticals Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=TLX&period=max&api_key=YOUR_API_KEY